MedTrace Logo

Aspire In Vitro Maturation Study

NCT07789730 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-08-27

No results posted yet for this study

Summary

A study to assess the Capacitation - in-vitro maturation (CAPA-IVM) system as an option for patients with a good ovarian reserve to achieve pregnancy.

Conditions

  • Infertility
  • In Vitro Maturation of Oocytes
  • Assisted Reproduction Technologies

Interventions

DEVICE

CAPA-IVM

CAPA-IVM is a two-step IVM process to mature oocytes in the laboratory after egg retrieval.

Sponsors & Collaborators

  • Lavima Fertility

    collaborator UNKNOWN

  • Inception Fertility Research Institute, LLC

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
37 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-26
Primary Completion
2028-02-29
Completion
2028-02-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07789730 on ClinicalTrials.gov